Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Pathol Oncol Res
2014 Jul 01;203:641-8. doi: 10.1007/s12253-014-9743-4.
Show Gene links
Show Anatomy links
TPX2 overexpression in medullary thyroid carcinoma mediates TT cell proliferation.
Yang X
,
Liu G
,
Xiao H
,
Yu F
,
Xiang X
,
Lu Y
,
Li W
,
Liu X
,
Li S
.
???displayArticle.abstract??? TPX2 (targeting protein for xenopus kinesin-like protein 2), a microtubule-associated protein, plays an important role in the formation of the mitotic spindle. Abnormal expression of TPX2 in various types of malignant tumors has been reported, but less is known for medullary thyroid cancer (MTC). We investigated the expression of TPX2 in human MTC tissues and its potential use as a therapeutic target. Immunohistochemical analysis of TPX2 expression was performed for 32 cases of MTC and 8 cases of normal thyroid. TPX2 expression was found to be significantly higher in MTC compared to normal thyroid tissues (P < 0.05), and to be associated with tumor size, lymph node metastasis, and advanced disease stage. The cellular effects of TPX2 knockdown, including cell proliferation, apoptosis, cell cycle diffusions, and mitotic gene expression were investigated using small interfering RNA (siRNA). TPX2-siRNA caused G1 and G2-phase cell cycle arrest, inhibited cell proliferation, and induced apoptosis. TPX2-siRNA also downregulated Aurora-A and cyclinB1 protein expression in MTC cells and enhanced the expression of p53 protein (P < 0.05). These results suggest that TPX2 may be of potential use as a new marker for MTC prognosis and therapy.
Aguirre-Portolés,
Tpx2 controls spindle integrity, genome stability, and tumor development.
2012,
Pubmed
Baldini,
Aurora kinases are expressed in medullary thyroid carcinoma (MTC) and their inhibition suppresses in vitro growth and tumorigenicity of the MTC derived cell line TT.
2011,
Pubmed
Bayliss,
Determinants for Aurora-A activation and Aurora-B discrimination by TPX2.
2004,
Pubmed
,
Xenbase
Carson,
Cancer progression and p53.
1995,
Pubmed
Chang,
The TPX2 gene is a promising diagnostic and therapeutic target for cervical cancer.
2012,
Pubmed
Eyers,
A novel mechanism for activation of the protein kinase Aurora A.
2003,
Pubmed
,
Xenbase
Ferchichi,
Assessment of Aurora A kinase expression in breast cancer: a tool for early diagnosis?
2013,
Pubmed
Janssen,
Genetic instability: tipping the balance.
2013,
Pubmed
Katayama,
Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53.
2004,
Pubmed
Kufer,
Human TPX2 is required for targeting Aurora-A kinase to the spindle.
2002,
Pubmed
,
Xenbase
Lee,
Targeting Aurora kinases for the treatment of prostate cancer.
2006,
Pubmed
Li,
Expression of targeting protein for Xenopus kinesin-like protein 2 is associated with progression of human malignant astrocytoma.
2010,
Pubmed
,
Xenbase
Lin,
[TPX2 expression and its significance in squamous cell carcinoma of lung].
2006,
Pubmed
Liu,
Aurora-A abrogation of p53 DNA binding and transactivation activity by phosphorylation of serine 215.
2004,
Pubmed
Marumoto,
Aurora-A - a guardian of poles.
2005,
Pubmed
,
Xenbase
Marumoto,
Roles of aurora-A kinase in mitotic entry and G2 checkpoint in mammalian cells.
2002,
Pubmed
,
Xenbase
Mohsenifar,
Prognostic values of proliferative markers ki-67 and repp86 in breast cancer.
2007,
Pubmed
Moore,
In the wrong place at the wrong time: does cyclin mislocalization drive oncogenic transformation?
2013,
Pubmed
Morgan-Lappe,
Identification of Ras-related nuclear protein, targeting protein for xenopus kinesin-like protein 2, and stearoyl-CoA desaturase 1 as promising cancer targets from an RNAi-based screen.
2007,
Pubmed
,
Xenbase
Pascreau,
Phosphorylation of p53 is regulated by TPX2-Aurora A in xenopus oocytes.
2009,
Pubmed
,
Xenbase
Rahmani,
Clinical management and outcomes of papillary, follicular and medullary thyroid cancer surgery.
2013,
Pubmed
Rieder,
Mitosis in vertebrates: the G2/M and M/A transitions and their associated checkpoints.
2011,
Pubmed
Sasayama,
Over-expression of Aurora-A targets cytoplasmic polyadenylation element binding protein and promotes mRNA polyadenylation of Cdk1 and cyclin B1.
2005,
Pubmed
,
Xenbase
Schmittgen,
Analyzing real-time PCR data by the comparative C(T) method.
2008,
Pubmed
Shigeishi,
Expression of TPX2 in salivary gland carcinomas.
2009,
Pubmed
Sillars-Hardebol,
TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression.
2012,
Pubmed
Simard,
Cancers with increasing incidence trends in the United States: 1999 through 2008.
2012,
Pubmed
Tonon,
High-resolution genomic profiles of human lung cancer.
2005,
Pubmed
Trimboli,
Trend in thyroid carcinoma size, age at diagnosis, and histology in a retrospective study of 500 cases diagnosed over 20 years.
2006,
Pubmed
Ulisse,
Expression of Aurora kinases in human thyroid carcinoma cell lines and tissues.
2006,
Pubmed
Warner,
Validation of TPX2 as a potential therapeutic target in pancreatic cancer cells.
2009,
Pubmed
Wittmann,
The spindle: a dynamic assembly of microtubules and motors.
2001,
Pubmed
